Pulmatrix, Inc. (PULM)
1.56
+0.16
(+11.83%)
USD |
NASDAQ |
Sep 09, 12:07
Pulmatrix Price to Book Value : 3.581 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.202 |
| September 04, 2026 | 3.191 |
| September 03, 2026 | 3.122 |
| September 02, 2026 | 3.374 |
| September 01, 2026 | 3.501 |
| August 31, 2026 | 3.374 |
| August 28, 2026 | 3.466 |
| August 27, 2026 | 3.489 |
| August 26, 2026 | 3.501 |
| August 25, 2026 | 3.673 |
| August 24, 2026 | 3.558 |
| August 21, 2026 | 3.432 |
| August 20, 2026 | 3.443 |
| August 19, 2026 | 3.489 |
| August 18, 2026 | 3.558 |
| August 17, 2026 | 3.581 |
| August 14, 2026 | 3.535 |
| August 13, 2026 | 3.466 |
| August 12, 2026 | 3.673 |
| August 11, 2026 | 3.673 |
| August 10, 2026 | 3.604 |
| August 07, 2026 | 3.811 |
| August 06, 2026 | 3.811 |
| August 05, 2026 | 3.788 |
| August 04, 2026 | 3.811 |
| Date | Value |
|---|---|
| August 03, 2026 | 3.994 |
| July 31, 2026 | 3.994 |
| July 30, 2026 | 3.902 |
| July 29, 2026 | 3.834 |
| July 28, 2026 | 3.857 |
| July 27, 2026 | 3.971 |
| July 24, 2026 | 3.788 |
| July 23, 2026 | 4.063 |
| July 22, 2026 | 3.880 |
| July 21, 2026 | 3.902 |
| July 20, 2026 | 3.857 |
| July 17, 2026 | 3.880 |
| July 16, 2026 | 3.696 |
| July 15, 2026 | 3.604 |
| July 14, 2026 | 3.719 |
| July 13, 2026 | 3.834 |
| July 10, 2026 | 3.948 |
| July 09, 2026 | 4.132 |
| July 08, 2026 | 4.316 |
| July 07, 2026 | 3.971 |
| July 06, 2026 | 3.971 |
| July 02, 2026 | 3.948 |
| July 01, 2026 | 3.994 |
| June 30, 2026 | 3.902 |
| June 29, 2026 | 2.254 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.717 |
| Corcept Therapeutics, Inc. | 17.83 |
| Veru, Inc. | 1.526 |
| Johnson & Johnson | 7.610 |
| Eli Lilly & Co. | 31.33 |
Price to Book Value Related Metrics
| Price | 1.56 |
| Earnings Yield | -70.71% |
| Market Cap | 5.698M |